Fluorotronics USA Inc



Farid Menaa, Professor, principal investigator, Director, consultant editor, reviewer, event organizer and entrepreneur, he earned his degrees with highest distinctions from prestigious French universities and institutions. He followed a post-doctoral in oncology as a NIH-fellow (San Diego, California, USA; 2004-2007). Subsequently, he pursued his career in dermatology, and stem cells as a DFG-Fellow (Wuerzburg, Germany; 2007-2009). Then, he was promoted as Chief Scientific Officer and Vice-President R&D at Fluorotronics, Inc. (CA, USA; 2009-2010), a nanotechnology and fluorine chemical company. Eventually, he was appointed Principal Investigator in Hematology and Genomics as a FAPESP-Fellow (Sao Paulo, Brazil; 2010-2012). His main current focuses are related to preventive, personalized, translational, integrative and nanomedicine, especially in the areas of oncology, regenerative medicine and gerontology, in order to prevent and implement early diagnosis and efficient therapy.